Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Breast Cancer · Breast Neoplasms · Breast Cancers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Baylor University Medical Center, Baylor Charles A Sammons Cancer Center, Dallas, Texas, United States
Study leads
Joyce A O'Shaughnessy, MD
Principal Investigator
Baylor Scott & White The Heart Hospital